Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,741 | 587 | 66.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,600 | 4 | 27.3% |
| Honoraria | $500.00 | 1 | 2.4% |
| Travel and Lodging | $338.00 | 1 | 1.6% |
| Gift | $177.47 | 1 | 0.9% |
| Consulting Fee | $100.00 | 1 | 0.5% |
| Education | $76.39 | 3 | 0.4% |
| Unspecified | $0 | 8 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $6,410 | 45 | $0 (2024) |
| SN Holdings, LLC | $1,143 | 8 | $0 (2024) |
| PFIZER INC. | $787.94 | 40 | $0 (2024) |
| Janssen Biotech, Inc. | $771.76 | 29 | $0 (2024) |
| Astellas Pharma US Inc | $745.06 | 41 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $657.17 | 35 | $0 (2022) |
| Sumitomo Pharma America, Inc. | $615.03 | 31 | $0 (2024) |
| NeoTract Inc. | $543.60 | 7 | $0 (2019) |
| Myriad Genetic Laboratories, Inc. | $484.14 | 18 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $464.20 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,018 | 70 | Sumitomo Pharma America, Inc. ($283.83) |
| 2023 | $3,117 | 87 | SN Holdings, LLC ($1,143) |
| 2022 | $2,140 | 107 | Janssen Biotech, Inc. ($275.35) |
| 2021 | $1,767 | 97 | Myovant Sciences Inc. ($216.63) |
| 2020 | $1,062 | 48 | Ferring Pharmaceuticals Inc. ($139.15) |
| 2019 | $1,507 | 57 | NeoTract Inc. ($221.54) |
| 2018 | $2,450 | 54 | AbbVie, Inc. ($1,270) |
| 2017 | $6,473 | 86 | AbbVie, Inc. ($4,665) |
All Payment Transactions
606 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: HORMONE THERAPY | ||||||
| 12/05/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $30.44 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $146.13 | General |
| Category: Urology | ||||||
| 12/04/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 12/02/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $27.38 | General |
| Category: ONCOLOGY | ||||||
| 11/27/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: HORMONE THERAPY | ||||||
| 11/19/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2024 | AngioDynamics, Inc. | NANOKNIFE (Device) | Food and Beverage | In-kind items and services | $34.80 | General |
| Category: OS | ||||||
| 11/01/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: UROLOGY | ||||||
| 10/30/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.44 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/10/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $31.40 | General |
| Category: Oncology | ||||||
| 10/08/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: UROTHELIAL CANCER | ||||||
| 09/25/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: HORMONE THERAPY | ||||||
| 09/18/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: ONCOLOGY | ||||||
| 08/28/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $29.74 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/22/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 08/21/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: UROTHELIAL CANCER | ||||||
| 08/20/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: ONCOLOGY | ||||||
| 08/15/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: HORMONE THERAPY | ||||||
| 08/14/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: HORMONE THERAPY | ||||||
| 08/12/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: ONCOLOGY | ||||||
| 08/05/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 07/18/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: ONCOLOGY | ||||||
| 07/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $29.98 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/11/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $20.99 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 2,951 | 5,251 | $669,822 | $160,253 |
| 2022 | 21 | 2,692 | 3,475 | $772,352 | $153,635 |
| 2021 | 38 | 3,231 | 4,311 | $873,130 | $207,199 |
| 2020 | 27 | 1,986 | 2,473 | $661,802 | $124,511 |
All Medicare Procedures & Services
114 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 760 | 1,102 | $187,340 | $60,240 | 32.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 241 | 283 | $70,750 | $22,355 | 31.6% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 89 | 95 | $49,970 | $15,174 | 30.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 160 | 160 | $40,160 | $11,332 | 28.2% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 19 | 21 | $22,463 | $6,641 | 29.6% |
| 52352 | Removal or manipulation of stone in ureter or kidney using an endoscope | Facility | 2023 | 24 | 24 | $21,356 | $6,168 | 28.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 467 | 715 | $7,150 | $5,943 | 83.1% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 62 | 62 | $29,450 | $5,745 | 19.5% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 227 | 299 | $21,528 | $5,388 | 25.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 29 | 31 | $13,516 | $3,005 | 22.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 44 | 46 | $24,196 | $2,573 | 10.6% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 13 | 13 | $8,164 | $2,425 | 29.7% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 30 | 32 | $40,227 | $2,398 | 6.0% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2023 | 82 | 82 | $6,424 | $1,961 | 30.5% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 26 | 28 | $8,624 | $1,721 | 20.0% |
| 52441 | Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | Facility | 2023 | 11 | 11 | $27,500 | $1,678 | 6.1% |
| 52442 | Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | Facility | 2023 | 11 | 42 | $75,600 | $1,552 | 2.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 380 | 510 | $3,570 | $1,099 | 30.8% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 20 | 28 | $2,044 | $708.12 | 34.6% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 78 | 82 | $3,280 | $576.74 | 17.6% |
| 86316 | Analysis for detection of tumor marker | Office | 2023 | 25 | 25 | $2,000 | $509.75 | 25.5% |
| 84154 | Psa (prostate specific antigen) measurement, free | Office | 2023 | 26 | 26 | $1,950 | $468.52 | 24.0% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 101 | 122 | $1,342 | $377.21 | 28.1% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 14 | 1,400 | $1,050 | $153.55 | 14.6% |
| 82565 | Blood creatinine level | Office | 2023 | 12 | 12 | $168.00 | $60.24 | 35.9% |
About Dr. John Hassan, MD
Dr. John Hassan, MD is a Urology healthcare provider based in Franklin, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497721526.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Hassan, MD has received a total of $20,533 in payments from pharmaceutical and medical device companies, with $2,018 received in 2024. These payments were reported across 606 transactions from 73 companies. The most common payment nature is "Food and Beverage" ($13,741).
As a Medicare-enrolled provider, Hassan has provided services to 10,860 Medicare beneficiaries, totaling 15,510 services with total Medicare billing of $645,599. Data is available for 4 years (2020–2023), covering 114 distinct procedure/service records.
Practice Information
- Specialty Urology
- Other Specialties Urology
- Location Franklin, TN
- Active Since 02/28/2006
- Last Updated 06/26/2017
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1497721526
Products in Payments
- Androgel (Drug) $5,935
- XTANDI (Drug) $1,002
- BOTOX (Biological) $743.98
- ORGOVYX (Drug) $721.51
- XIAFLEX (Biological) $648.57
- PROVENGE (Drug) $442.20
- GEMTESA (Drug) $425.71
- ELIGARD (Drug) $391.90
- JELMYTO (Drug) $376.61
- FIRMAGON (Drug) $344.41
- UroLift (Device) $333.73
- KEYTRUDA (Biological) $324.20
- Axonics (Device) $315.96
- PROLARIS (Device) $289.84
- MYRBETRIQ (Drug) $271.73
- ERLEADA (Drug) $230.09
- INTERSTIM (Device) $226.73
- Natesto (Drug) $223.15
- Urolift - UL400 (Device) $209.87
- UroLift System (Device) $199.83
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Franklin
Dr. Daniel Salvas, M.d, M.D
Urology — Payments: $18,088
Dr. John Selph, Md, MD
Urology — Payments: $16,226
Mark Dickinson, Md, MD
Urology — Payments: $10,253
William Tissot, Md, MD
Urology — Payments: $7,687
Sergio Giancola
Urology — Payments: $7,616
Joel Locke, Md, MD
Urology — Payments: $6,988